H1 Blog

JULY 24, 2023

Strategies for Market Access Teams One thing the healthcare ecosystem lacks in the United States is a system of shareable, actionable healthcare data. According to a study by DRG Digital’s Manhattan Research , drugmakers are still mostly focused on reaching payers through traditional, in-person account manager relationships.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Treatment Pharmacy 52

Practical Cheminformatics

JANUARY 8, 2024

Aside from some very brief demos on code generation and literature searches, mentions of LLM applications in preclinical research were scarce. A preprint from Microsoft AI Research provided a broad catalog of potential LLM applications in the physical and life sciences. Most of the drug discovery examples were underwhelming.

Drugs 139

Drugs Small Molecule Bioinformatics Packaging 139

H1 Blog

SEPTEMBER 26, 2023

Using artificial intelligence (AI), especially Generative AI, predictive analytics, companies can access reliable datasets, allowing informed decisions about where to conduct research without needing onsite visits or relying on outdated resources. Request a demo of Trial Landscape.

Trials 59

Trials Clinical Trials International Regulations 59

H1 Blog

JUNE 7, 2023

Performance data can also lead to more efficient and cost-effective trial designs by allowing research teams to identify areas in which additional resources may be needed to support successful outcomes. The Michael J.

Trials 52

Trials Clinical Trials Pharma Companies Clinical Development 52

sptlabtech

DECEMBER 2, 2022

Lowering costs to unlock wider innovation One of the drivers behind the proliferation of new research activities in genomics is the widely known fact that sequencing costs are falling all the time. We've seen the cost of sequencing continually go down with new sequencing platforms coming onto the market.

International 52

International Laboratories Research Marketing 52

Codon

MAY 30, 2023

Codon Digest is my weekly roundup of research, news, and industry highlights about engineered biology. The researchers first compared the editing efficiency of different versions of IscB when coupled with 'ωRNA,' which guides the enzyme to the right spot on the DNA. Nucleic Acids Research. Please send me your feedback.

DNA 52

DNA RNA Engineering Vaccine 52

Codon

MAY 30, 2023

Codon Digest is my weekly roundup of research, news, and industry highlights about engineered biology. The researchers first compared the editing efficiency of different versions of IscB when coupled with 'ωRNA,' which guides the enzyme to the right spot on the DNA. Nucleic Acids Research. Please send me your feedback.

DNA 52

DNA RNA Engineering Vaccine 52

Agency IQ

MAY 31, 2024

and 2 mg [EMA] Product-specific bioequivalence guidance 6/30/2024 Pharmeuropa 36.2

Regulations 40

Regulations Production Compliance Pharmaceuticals 40

The Pharma Data

MAY 14, 2021

You can’t learn these “forbidden” exercises from some internet copy of an ancient ninja scroll some “collector” got off the black market. These Forbidden Fitness Secrets of A Modern Day Ninja Warrior are the result several decades of obsessive training and research. Anyway, that’s NOT what this is about. ” — Jeffry C.

Packaging 52

Packaging Production Vaccine International 52

H1 Blog

DECEMBER 18, 2023

Pharmaceutical companies are on the brink of a tech revolution, and will embrace AI as a means to enhance their operations and research capabilities. In the near term, AI will be all about saving time, simplifying work processes, and knocking down language and jargon barriers in healthcare and clinical research.

Trials 64

Trials Clinical Trials FDA Pharmaceutical Companies 64

Agency IQ

DECEMBER 1, 2023

Expected Action Description of action Date Eudamed Module: Market Surveillance [E.U.] Completed development of the EUDAMED Market Surveillance module Q4 2023 Designation of E.U. Expected Action Description of action Original Deadline Pharmaceuticals – changes to marketing authorisations (review of EU rules) [E.U.]

Regulations 40

Regulations Clinical Trials Production Biosimilars 40

H1 Blog

NOVEMBER 29, 2023

Every day, patients around the globe are waiting for life-saving treatments to reach the market. Without access to all the relevant data, researchers are unable to fully understand the complexities of diseases and develop effective treatments. One major barrier to data sharing is the lack of consistency in clinical trial registries.

Clinical Trials 59

Clinical Trials Trials Drug Development Treatment 59

Agency IQ

MARCH 29, 2024

April 2024 Market-Based Approaches Under the National Pollutant Discharge Elimination System (NPDES) Program (Proposed Rule Stage) 2040-AG02 EPA supports market-based mechanisms, including water quality trading under the Clean Water Act (CWA). EPA plans to continue its outreach efforts with affected parties.

Regulations 40

Regulations Compliance Production Government 40

Translation

MARCH 25, 2025

When R&D teams, marketing, consumer insights and procurement align early in the process, it not only speeds up innovation but also ensures products are launched with greater strategic alignment and fewer disruptions. Ready to bring your next innovation to market faster? The solution? Collaboration.

Production 52

Production International Marketing Compliance 52

Perficient: Drug Development

JANUARY 14, 2025

Recent research shows that the global B2B e-commerce market is expected to surge from $28.86 For example, a buyer researching your product catalog online adds items to their cart but pauses to confirm specs with a colleague in the warehouse via a mobile device. This shift isnt just a trendits a revolution.

Marketing 52

Marketing Testimonials Production Research 52